VERICEL CORPORATION (VCEL) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
64/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 10 wins, 2 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q23/3 |
WinVCEL / S&P 38.30% / 15.20% |
WinVCEL / S&P 22.95% / 15.00% |
WinVCEL / S&P 261.54% / 50.40% |
| 2026-Q12/3 |
LoseVCEL / S&P -10.66% / -4.33% |
WinVCEL / S&P 22.45% / 11.30% |
WinVCEL / S&P 950.00% / 27.70% |
| 2025-Q43/3 |
WinVCEL / S&P 14.43% / 2.65% |
WinVCEL / S&P 16.45% / 9.00% |
WinVCEL / S&P 63.16% / 13.40% |
| 2025-Q32/3 |
LoseVCEL / S&P -26.04% / 8.12% |
WinVCEL / S&P 14.05% / 4.61% |
WinVCEL / S&P 257.14% / 13.45% |
| 2025-Q22/3 |
LoseVCEL / S&P -4.64% / 10.94% |
WinVCEL / S&P 16.13% / 4.83% |
WinVCEL / S&P 1200.00% / 10.63% |
| 2025-Q12/3 |
LoseVCEL / S&P -18.74% / -4.27% |
WinVCEL / S&P 14.80% / 4.98% |
WinVCEL / S&P 288230376151711712.00% / 10.57% |
| 2024-Q42/3 |
WinVCEL / S&P 29.96% / 2.41% |
WinVCEL / S&P 20.10% / 5.25% |
LoseVCEL / S&P -337.50% / 6.15% |
| 2024-Q31/3 |
LoseVCEL / S&P -7.91% / 5.89% |
WinVCEL / S&P 22.48% / 5.89% |
LoseVCEL / S&P -131.82% / 6.11% |
| 2024-Q21/3 |
LoseVCEL / S&P -11.80% / 4.28% |
WinVCEL / S&P 20.54% / 5.38% |
LoseVCEL / S&P -103.57% / 5.12% |
| 2024-Q12/3 |
WinVCEL / S&P 46.08% / 10.56% |
WinVCEL / S&P 23.05% / 5.71% |
LoseVCEL / S&P -100.00% / 5.59% |
| 2023-Q41/3 |
LoseVCEL / S&P 6.24% / 11.69% |
WinVCEL / S&P 20.66% / 6.81% |
LoseVCEL / S&P -77.14% / 7.78% |
| 2023-Q31/3 |
LoseVCEL / S&P -10.78% / -3.27% |
WinVCEL / S&P 17.18% / 7.52% |
LoseVCEL / S&P -42.11% / -5.03% |
| 2023-Q22/3 |
WinVCEL / S&P 28.14% / 8.74% |
WinVCEL / S&P 15.98% / 9.50% |
LoseVCEL / S&P -20.00% / -8.57% |
| 2023-Q12/3 |
WinVCEL / S&P 11.31% / 7.50% |
LoseVCEL / S&P 8.73% / 10.77% |
WinVCEL / S&P 50.00% / -15.69% |
| 2022-Q42/3 |
WinVCEL / S&P 13.53% / 7.56% |
LoseVCEL / S&P 6.94% / 11.88% |
WinVCEL / S&P 118.75% / -17.99% |
| 2022-Q30/3 |
LoseVCEL / S&P -7.86% / -4.88% |
LoseVCEL / S&P 5.17% / 13.47% |
LoseVCEL / S&P -3900.00% / -1.41% |
| 2022-Q20/3 |
LoseVCEL / S&P -34.12% / -16.10% |
LoseVCEL / S&P 3.97% / 13.71% |
LoseVCEL / S&P -275.00% / 11.04% |
| 2022-Q12/3 |
WinVCEL / S&P -2.75% / -4.60% |
WinVCEL / S&P 20.47% / 15.97% |
LoseVCEL / S&P -340.00% / 42.23% |
| 2021-Q41/3 |
LoseVCEL / S&P -19.47% / 11.03% |
WinVCEL / S&P 25.50% / 15.00% |
LoseVCEL / S&P -328.57% / 96.40% |
| 2021-Q31/3 |
LoseVCEL / S&P -7.05% / 0.58% |
WinVCEL / S&P 28.33% / 10.77% |
LoseVCEL / S&P -50.00% / 69.42% |
| 2021-Q22/3 |
LoseVCEL / S&P -5.49% / 8.55% |
WinVCEL / S&P 26.59% / 6.58% |
WinVCEL / S&P 1900.00% / 51.81% |
| 2021-Q12/3 |
WinVCEL / S&P 79.89% / 6.17% |
WinVCEL / S&P 5.05% / -1.06% |
LoseVCEL / S&P VCEL unavailable / 7.39% |
| 2020-Q42/3 |
WinVCEL / S&P 66.65% / 12.15% |
WinVCEL / S&P 3.49% / -3.72% |
LoseVCEL / S&P VCEL unavailable / -33.42% |
| 2020-Q32/3 |
WinVCEL / S&P 34.08% / 8.93% |
WinVCEL / S&P 6.66% / -2.04% |
LoseVCEL / S&P VCEL unavailable / -27.10% |
| 2020-Q22/3 |
WinVCEL / S&P 50.71% / 20.54% |
WinVCEL / S&P 14.54% / -0.46% |
LoseVCEL / S&P VCEL unavailable / -27.11% |
| 2020-Q11/3 |
LoseVCEL / S&P -47.30% / -19.60% |
WinVCEL / S&P 29.67% / 3.47% |
LoseVCEL / S&P VCEL unavailable / -14.75% |
| 2019-Q42/3 |
WinVCEL / S&P 14.93% / 9.07% |
WinVCEL / S&P 29.71% / 5.36% |
LoseVCEL / S&P VCEL unavailable / 2.99% |
| 2019-Q31/3 |
LoseVCEL / S&P -19.85% / 1.70% |
WinVCEL / S&P 34.37% / 5.02% |
LoseVCEL / S&P VCEL unavailable / 0.21% |
| 2019-Q22/3 |
WinVCEL / S&P 7.88% / 4.30% |
WinVCEL / S&P 38.51% / 6.64% |
LoseVCEL / S&P VCEL unavailable / 8.65% |
| 2019-Q11/3 |
LoseVCEL / S&P 0.63% / 13.65% |
WinVCEL / S&P 32.50% / 8.12% |
LoseVCEL / S&P VCEL unavailable / 14.29% |
| 2018-Q42/3 |
WinVCEL / S&P 22.97% / -13.52% |
WinVCEL / S&P 44.77% / 9.05% |
LoseVCEL / S&P VCEL unavailable / 18.23% |
| 2018-Q32/3 |
WinVCEL / S&P 45.88% / 7.71% |
WinVCEL / S&P 43.10% / 10.21% |
LoseVCEL / S&P VCEL unavailable / 19.06% |
| 2018-Q21/3 |
LoseVCEL / S&P -2.51% / 3.43% |
WinVCEL / S&P 36.67% / 9.03% |
LoseVCEL / S&P VCEL unavailable / 14.46% |
| 2018-Q12/3 |
WinVCEL / S&P 82.57% / -0.76% |
WinVCEL / S&P 43.90% / 7.68% |
LoseVCEL / S&P VCEL unavailable / 12.46% |
| 2017-Q41/3 |
LoseVCEL / S&P -9.17% / 6.64% |
WinVCEL / S&P 15.40% / 7.03% |
LoseVCEL / S&P VCEL unavailable / 13.82% |
| 2017-Q32/3 |
WinVCEL / S&P 81.82% / 4.48% |
WinVCEL / S&P 7.16% / 5.68% |
LoseVCEL / S&P VCEL unavailable / 17.57% |
| 2017-Q21/3 |
WinVCEL / S&P 17.86% / 3.09% |
LoseVCEL / S&P 0.20% / 4.83% |
LoseVCEL / S&P VCEL unavailable / 17.74% |
| 2017-Q10/3 |
LoseVCEL / S&P -6.67% / 6.07% |
LoseVCEL / S&P -8.80% / 3.67% |
LoseVCEL / S&P VCEL unavailable / 13.32% |
| 2016-Q42/3 |
WinVCEL / S&P 7.14% / 3.82% |
WinVCEL / S&P 6.28% / 2.09% |
LoseVCEL / S&P VCEL unavailable / 7.05% |
| 2016-Q32/3 |
WinVCEL / S&P 24.44% / 3.85% |
WinVCEL / S&P 5.60% / 0.20% |
LoseVCEL / S&P VCEL unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | VCEL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 13.26% | 20.78% |
| Annualized return | 13.26% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | VCEL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -27.09% | 83.14% |
| Annualized return | -6.12% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | VCEL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 1746.64% | 319.30% |
| Annualized return | 33.86% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |